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ABSTRACT  The ability  of phorbol  derivatives to function  as stimulating agents for superoxide 
(02-) release by guinea pig neutrophils has been evaluated and compared to the known ability 
of each compound to activate protein  kinase C. Those that activate the kinase also stimulate 
02- release, while those that are inactive with  respect to the kinase have no effect on 02- 
release. The same correlation  was observed with  respect to the ability  of phorbol  esters to 
induce  morphological  changes in  neutrophils,  i.e., vesiculation  and  reduction  in  granule 
content. Certain phenothiazines and naphthalene sulfonamides that are known antagonists of 
calcium-binding  proteins blocked both phorbol ester-induced O~- release and morphological 
changes in these cells. 
Upon stimulation, neutrophils undergo a dramatic series of 
biochemical and  morphological changes.  They display en- 
hanced oxygen consumption that is used in the production of 
superoxide (02-) 1 (for reviews see references 3 and 4). Con- 
comitant with this increase in  oxidative metabolism is the 
release of enzymes and other proteins from intracellular gran- 
ules through exocytotic processes and alterations in cellular 
morphology (e.g., 7,  16, 23). 
A number of soluble and particulate agents stimulate neu- 
trophils to varying degrees. Particulate stimuli (e.g., opsonized 
zymosan particles) induce production of 02- and morpholog- 
ical  alterations after binding  and  internalization (e.g.,  14). 
Soluble or 'quasi'-soluble stimuli include substances that exert 
their effects either by partitioning into and disordering mem- 
branes (e.g., digitonin, cis-unsaturated fatty acids) (e.g. 7,  11) 
or by binding to specific receptors in these cells, (e.g., immune 
complexes,  chemotactic  peptides)  (e.g.,  8,  24).  The  latter 
group includes 4-fl-phorbol  12-myristate  13-acetate  (PMA) 
(37).  The major binding site for PMA in all cells examined 
t Abbreviations  used in  this paper.  CPZ, chlorpromazine; CPZ-SO, 
chlorpromazine sulfoxide; Me2SO, dimethylsulfoxide; O2-, superox- 
ide; PMA, 4-fl-phorbol 12-myristate 13-acetate;  PMZ, promethazine; 
TFP,  trifluoperazine; TFP-SO, trifluoperazine sulfoxide; Ws,  N-(6- 
aminohexyl)-l-naphthalene  sulfonamide;  W7,  N-(6-aminohexyl)-5- 
chloro- l-naphthalene sulfonamide. 
thus far is the Ca2+-activated, phospholipid-dependent protein 
kinase (protein kinase C) (9,  35,  45).  High levels of activity 
for protein kinase C are found in neutrophils (21), and specific 
binding of PMA to these cells has been demonstrated (20, 28, 
44).  We have previously shown that suboptimal concentra- 
tions of PMA and Ca2÷-ionophore  A23187 stimulate neutro- 
phils synergistically  (39). 
To characterize further the  interaction of phorbol esters 
with neutrophils, we have compared the ability of a spectrum 
of phorbol derivatives to stimulate both morphological alter- 
ations and 02- production in these cells. Comparative studies 
on the ability ofphorbol esters to effect  morphological changes 
in  neutrophils are  lacking.  In  addition,  the list  of phorbol 
esters tested as stimulating agents for 02- release has been 
expanded. Phenothiazines and naphthalene sulfonamides in- 
hibit both responses.  The inhibition  of O2-  release  by the 
drugs is reversible,  in contrast to an earlier study (12). This is 
the first report, to our knowledge, that antagonists of Ca  ++- 
binding proteins block morphological changes in neutrophils. 
MATERIALS AND  METHODS 
Reagents:  Trifluoperazine (TFP), chlorpromazine (CPZ), prometha- 
zine (PMZ), ferricytochyrome  c (type VI), xanthine oxidase,  Triton X-100, and 
all of the phorbol derivatives  of Table I were purchased from Sigma Chemical 
Co., St. Louis, MO. Trifluoperazine sulfoxide (TFP-SO) and chlorpromazine 
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© The Rockefeller University Press - 0021-9525/85/09/1052•07 $1.00 sulfoxide  (CPZ-SO)  were  gifts  from  Smith  Kline  &  French  Laboratories, 
Philadelphia,  PA. N-(6-aminohexyl)-5-chloro-l-naphthalene  sulfonamide (WT) 
and  N-(6-aminohexyl)-l-naphthalene  sulfonamide  (W~) were obtained  from 
Rikaken Co.,  Ltd., Nagoya, Japan.  Calmidazolium  (compound No. R24571) 
was obtained  from Janssen  Pharamaceutica,  Beerse, Belgium. Glutaraldehyde 
was obtained from Polysciences, Inc., Warrington, PA and from Alfa Products, 
Danvers,  MA. Osmium tetroxide was purchased  from Alfa Products.  Tannic 
acid (No.  1764) was obtained  from Mallinckrodt,  Inc., St. Louis, MO. Epon 
812 was purchased  from Balzers Union,  Hudson, NH. Sodium caseinate was 
obtained  from Fisher Scientific Co., Pittsburg, PA. All other chemicals were of 
the highest available grade. Distilled-deionized water was supplied by a Barn- 
stead ultrapure  filtration system (Barnstead Co,, Boston, MA). 
Preparation of Cells:  Neutrophils were harvested from the peritonea 
of guinea pigs (600-1,000  g) (Rockland,  Inc., Gilbertville, PA)  18 h after the 
injection of sterile sodium caseinate as previously described (17). Cell viability 
as  measured  by trypan  blue exclusion  was always >93%.  Cell number was 
determined  by direct microscope counting using a hemocytometer. 
02- Production:  02- release was monitored at 37"C by the continuous 
spectrophotometric  measurement of superoxide dismutase-inhibitable  reduc- 
tion of ferricytochrome c at 550 nm (l 1). The standard  assay mixture (l.0 ml) 
consisted of Dulbecco's  modified  Eagle's medium that was altered (138 mM 
NaCL 2.7 mM KCI, 16.2 mM Na2HPO4, 1,47 mM KH2PO4, 0.90 mM CaCl2, 
0.50  mM  MgCl2, 7.5  mM  D-glucose, pH  7.35) (18)  containing  0.075 mM 
ferricytochrome c and 106 cells/ml. The blank contained all of  the components 
listed above plus 20 ug/ml superoxide dismutase to correct for ferricytochrome 
c reduction  by agents other than 02-. The extinction  coefficient for reduced 
minus oxidized cytoehrome c at 550 nm was 20,000 M  -~ cm-' (30). 
Ultrastructural  Analysis:  Morphological  experiments  were  per- 
formed  at  a  cell concentration  of 1 x  106 cells/ml  in  10  ml  of the altered 
Dulbecco's modified Eagle's medium described above except ferricytochrome 
c was omitted.  Cells were fixed 5 min after stimulation  by rapidly adding  1.0 
ml of 25% glutaraldehyde. In some preparations,  the fixative was modified to 
contain  tannic  acid  as described  by  Maupin  and  Pollard  (29). Cells were 
postfixed in 2% OsO4 in 0.1  M phosphate buffer (pH 7.3) and then embedded 
in EPOn as a pellet. Thin sections were cut on a diamond knife and stained 
with uranyl acetate and lead citrate before they were examined in a Philips 200 
electron microscope (Philips Electronic Instruments, inc., Mahwah, NJ) oper- 
ated at 60 kV. At least 100 cells from each preparation were examined, and all 
observations were confirmed on at least three different preparations of cells. 
RESULTS 
Ability of Different  Phorbol Derivatives to 
Stimulate  Release of 02- 
Casein-elicited guinea pig neutrophils release  O2- at a rate 
of 51.4 +  9.9 (mean _+ SD) nmol O2-/min per 107 cells (n = 
24) when stimulated with an optimal concentration (30 ng/ 
ml)  of PMA.  The structural  specificity  of the stimulus was 
assessed  by testing various analogues of PMA (Table I). Only 
fl-isomers with both the 12- and 13- positions in ester linkage 
were active. The nature of the carboxylic acid (e.g., myristate, 
acetate,  benzoate) in  these  linkages  was  not crucial  in  the 
range examined. 
FIGURE  1  Electron micrographs of thin sections of guinea pig neutrophils in suspension. (A) Representative control cell that was 
incubated  in medium  for 8  min at 37°C  before fixation. This cell is typical of elicited guinea pig neutrophils in that it has large 
accumulations  of glycogen  (G)  (38)  and  numerous  electron  dense  intracellular granules.  Note  that there are few  intracellular 
vesicles, x  9,750.  (B)  Cell that was preincubated for 3  min  in medium at 37°C and then another 5  min after addition of PMA 
before fixation. This cell is typical of PMA-treated cells in that there are numerous cytoplasmic vesicles (arrowheads). Most of the 
glycogen (G) appears to be retained, but there is an apparent reduction  in the number of intracellular granules, x  9,700.  PMA 
was dissolved in Me2SO such that the final concentration of solvent was 0.25% (vol/vol) in all cases. This concentration of Me2SO 
did not affect the morphology of control cells. 
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Release and Morphological Alterations  in Neutrophils* 
Compound  O2- release* 
Degree of 
morpholog- 
ical altera- 
tion  ~ 
% activity 
4-fl-Phorbol 12-myristate 13-  100  ++++ (8) 
acetate 
4-fl-Phorbo112,  13-didecanoate  55 +  2.65 (3)  ++ (3) 
4-fl-Phorbo112,  13-dibenzoate  57 _+ 12.12 (3)  ++ (3) 
4-~-Phorbo112, 13-dibutyrate  40 +  7.94 (3)  ++ (3) 
4-fl-Phorbo112-monomyristate  0 +  0 (3)  -  (3) 
4-~-Phorbol 13-monomyristate  0 +_ 0 (3)  -  (3) 
4-fl-Phorbol  0 +_ 0 (3)  -  (3) 
4-a-Phorbo112, 13-didecanoate  0 +  0 (3)  -  (3) 
* Guinea pig neutrophils were subjected to the various  phorbol derivatives 
(30  ng/ml),  and  superoxide  release  and  morphological  alterations  were 
determined as described. Phorbol derivatives  were dissolved  in dimethyl 
sulfoxide such that the final  concentration of this  solvent  was 0.25% (vol/ 
vo[) in all cases. 
* The data for 02" release are expressed  as the mean  -  SD relative  to the 
rate observed with PMA. The number (n) of different cell preparations  used 
is given  in parentheses. 
The degree of morphological alteration was determined on cell preparations 
that were fixed 5 rain after addition of the phorbol derivative under study. 
The qualitative scale is: ++++, greatest degree of vesiculation  and granule 
loss; ++,  intermediate level  of vesiculation  and  granule  loss; -, no differ- 
ente from untreated control cells with regard to vesiculation  and  granule 
number. 
Ultrastructural Analysis of Neutrophils  Treated 
with Phorbol Derivatives 
Unstimulated  neutrophils  in  suspension  are  essentially 
spherical with a few short projections at the cell surface. These 
ceils contain numerous cytoplasmic granules and few vesicles 
(Fig.  1A).  Neutrophils  treated  in  suspension  with  certain 
phorbol derivatives exhibit a dramatic increase in intracellular 
vesicles and a decrease in cytoplasmic granules (Fig. 1 B). The 
specificity of the  phorbol  derivatives with  respect to  these 
changes in cellular morphology paralleled the potency of  these 
compounds  to  stimulate  02-  release  (Table  I).  All  of the 
observations reported here are restricted to 5 rain after expo- 
sure to  the  stimulus;  at this time,  the cells had  responded 
maximally in terms of the rate of 02- release (e.g.,  see Fig. 
2 C). Virtually all of the cells examined in each preparation 
responded similarly when exposed to a given stimulus. 
Effects of Phenothiazines and Naphthalene 
Sulfonamides  on 02- Release 
Certain phenothiazines and naphthalene sulfonamides that 
inhibit a variety of Ca2÷-dependent proteins (e.g., calmodulin 
[46],  protein kinase C  [32])  were tested for their effects on 
02- release from neutrophils stimulated with PMA. TFP or 
CPZ incubated with cells 3 min before stimulation inhibited 
O2- release in a cooperative manner (Hill coefficients =  3.2 
and  2.1,  respectively). Half-maximal inhibition  occurred at 
~5 uM TFP or  10 uM CPZ (Fig.  2, A and B).  Addition of 
TFP to cells after stimulation also caused an abrupt cessation 
of O2-  release (Fig.  2 C).  Other phenothiazines were tested 
(Table II). PMZ at 10 uM was less inhibitory than either TFP 
or CPZ. TFP-SO and CPZ-SO which are not antagonists of 
Ca++-binding proteins were inactive. Incubation of cells with 
the naphthalene sulfonamide W7 for 3 min before stimulation 
inhibited O2- release in a dose-dependent fashion. Half-max- 
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FIGURE  2  Effects of phenothiazines on superoxide release by PMA 
stimulated guinea  pig  neutrophils,  (A}  Dose-response  curve  for 
inhibition of Oz- release by TFP (@) and CPZ (O). Cells (I  x  I06/mi) 
were prelreated with  these drugs for 3  rain in the assay  mixture 
before stimulation with PMA (30 ng/ml). The percent inhibition was 
calculated from the equation (Vo -  V~/Vo)  x  100,  where Vo is the 
activity without inhibitor, and  V~  is the activity with  inhibitor.  (B) 
The Hill  plot for the data in A  (TFP, @; CPZ, O). This form of the 
Hill equation  is derived elsewhere by  Taketa and  Pogel (43).  (C) 
Reaction  progress curves  (continuous tracings) demonstrating the 
effects of TFP on the O2--dependent reduction of ferricytochrome 
c  by  neutrophils stimulated  with  PMA,  which  was added  last to 
initiate  the  reactions.  Curve  a  shows  the  initial  portion  of  the 
progress curve for 106 cells/ml. TFP (20 #M) inhibited 02- release 
when  it was added to the assay system 3  rain before stimulation 
(curve c) or to cells already stimulated (curve b). PMA was dissolved 
in Me2SO  such that the final concentration of solvent was 0.25% 
(vol/vol) in all cases.  This concentration of MezSO  did not affect 
Oz- release. 
imal inhibition with W7 occurred at -20 ~M, W5 (which is 
known not to interfere with Ca++-binding),  the unchlorinated 
analogue  of WT,  did  not  affect  02-  release  (Fig.  3).  The 
inhibitory  effects of TFP,  CPZ,  and  W7  were  completely 
reversed  by washing  the  cells  twice  in  drug-free  medium 
(Table II). The degree of inhibition with these phenothiazines 
and naphthalene sulfonamides was not affected by increasing 
the  cell  concentration  from  1.0  x  l0  6  to  2.5  X  106/ml. 
Therefore, the results obtained with both cell concentrations 
were analyzed together in  Table II. The potent calmodulin 
inhibitor Calmidozolium (compound No. R24571) was found 
to be extremely toxic to neutrophils over the concentration 
range in which it inhibits calmodulin (0.25-2.0 #M). 
Effects of Phenothiazines and Naphthalene 
Sulfonamides on  the  Ultrastructure  of 
Stimulated Neutrophi/s 
Addition  of TFP  (10  uM)  to  neutrophils  3  rain  before 
stimulation  with  PMA  blocks  the  ultrastructural  changes 
noted above. Cells so treated appear similar to unstimulated 
cells in that they contain few vesicles and a normal comple- 
ment of granules (Fig.  4).  In contrast,  similar treatment of 
cells with  10 uM  TFP-SO did  not block the PMA-induced 
alterations (Fig.  4B). The naphthalene sulfonamide W7 (50 
~M) also inhibited  the ultrastructural changes induced with 
PMA  (Fig.  5A),  whereas  Ws  (50  uM)  did  not  (Fig.  5B). ]'ABLE II.  Effects  of Phenothiazines and Naphthalene Sulfonamides 
on 02- Release by Neutrophils Stimulated with PMA: Ability to 
Reverse the Effects by Washing the Cells 
%  Activity 
Drug additions  Without washing  With washing 
None  100  108 ±  19.4 
TFP (10 uM)  18.5  4- 6.4  139 4- 28 
TFP-SO (10 uM)  102.3  4- 11.3  ND 
CPZ (10 ~M)  48.9 ±  5.9  125.3  4- 27.7 
CPZ-SO (10 #M)  "100.9 ±  1.2  ND 
PMZ (10 t~M)  79.3 4- 8.4  ND 
W7 (50/~M)  8.1  4-5.6  115.7_+  16.5 
W5 (50 t~M)  101.5  4- 14.5  ND 
Neutrophils were incubated in the standard assay  mixture for 3 min at 37°C 
with the compounds listed before stimulation with PMA. For experiments on 
reversibility, 5 ml of cells (2.5 x  106 cells/ml) were suspended in Dulbecco's 
modified  Eagle's medium and incubated with  the drugs for 3 rain at 37°C. 
The cells were then washed twice in ice-cold medium (10 ml), suspended in 
the assay cuvette at a concentration  of 2.5 x  106 cells/ml, and stimulated 
with PMA. Superoxide was measured as described in Materials and Methods. 
Data are expressed  as the mean -+ SD for three to eight different preparations 
of cells. 100% activity is that observed in the absence of drugs. None of the 
drugs utilized affected cell viability under the conditions employed or inhib- 
ited 02- detection  in an O~--generating system (i.e., xanthine oxidase plus 
purine). ND, not determined.  Three pairs of analogues were compared, as 
well  as PMZ, which  was only moderately effective. One member of each 
pair serves as a control,  i.e., is  known  not to interfere  with  Ca++-binding 
proteins. 
Treatment  of cells  with  10  uM  CPZ  or  PMZ  resulted  in 
partially inhibiting the morphological alterations induced by 
PMA,  while treatment with CPZ-SO  was  ineffective in this 
regard. None of these drugs appeared to affect  the ultrastruc- 
ture of unstimulated cells in suspension (data not shown). 
In agreement with these ultrastructural  observations, phe- 
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FIGURE  3  Effects  of  naph- 
thalene sulfonamides on  02- 
release  from  PMA-stimulated 
guinea  pig  neutrophils.  New 
trophils (106 cells/ml) were in- 
cubated  with  the  indicated 
concentrations  of  W7  {0)  or 
Ws  (O)  in  the  standard assay 
mixture for 3 rain at 37°C be- 
fore stimulation of 02- release 
with  PMA.  The  mean  inhibi- 
tion  of  02-  release ±  SD el- 
fected by these compounds at 50 uM is given by the error bars (n 
=  3). The dose response curves are those of a single representative 
experiment. Compounds Wr and Ws were dissolved in Me2SO such 
that the final concentration of this solvent in the assay was 0.25% 
(vol/vol) in all cases.  Thus, the total concentration of Me2SO was 
0.5% (drug plus PMA). This concentration of solvent did not affect 
02- release. 
FIGURE  4  Effects  of  TFP  and  TFP-SO  on  PMAqnduced  ultrastructural  changes  in  guinea  pig  neutrophils.  (A)  Cell  that  was 
incubated in  suspension for  3  rain  in  medium  containing 10 #M  TFP at 37°C and then another 5  rain after addition of PMA 
before fixation. Note that the cell has very few cytoplasmic vesicles (arrowheads). An adjacent cell has a prominent lipid droplet 
(LD). x  10,200.  (B) Cell that was preincubated for 3 rain in medium containing 10 #M TFP-SO at 37°C and then another 5 rain 
after addition of PMA before fixation. Note the presence of numerous cytoplasmic vesicles (arrowheads). Some vesicles contain 
electron  dense  material  (arrows),  which  is  presumed  to  be part of the contents  of granules that  have discharged  into  these 
vesicles, x  10,500. 
ROBINSON  ET  AL  PhorbolEster-stimulatedNeutrophils  1055 FIGURE  5  Effects of naphthalene sulfonamides on PMA-induced ultrastructural changes in guinea pig neutrophils. (A) Cell that 
was incubated in suspension for 3 min in medium containing 50 #M W7 at 37"C and then another 5 min after addition of PMA 
before fixation.  Note that the  cell  is  quite  round  in  appearance, has  numerous granules, and  has few  cytoplasmic vesicles 
(arrowheads). x  10,000. (B) Cell that was preincubated for 3 min in medium containing 50 #M Ws at 37°C and then another 5 
rain after addition of PMA before fixation. Note the presence of numerous cytoplasmic vesicles (arrowheads and a reduction in 
the number of granules, x  10,400. 
nothiazines inhibited the release of lysozyme from guinea pig 
neutrophils stimulated with PMA with the following order of 
potency: TFP>CPZ>PMZ> >TFP-SO (data not shown). The 
ability of TFP and W7 to inhibit release of granule enzymes 
from neutrophiis has been noted previously (e.g.,  1, 33, 41, 
42, 47). 
DISCUSSION 
Certain phorbol esters can intercalate into cellular membranes 
and  directly activate protein  kinase C  (e.g.,  9,  45).  In  the 
present study, we show that the same phorbol esters reported 
to  activate protein  kinase  C  stimulate  release  of 02-  and 
changes in morphology of guinea pig neutrophils, while those 
that do not activate kinase C did not affect neutrophils in the 
ways  indicated  (Table  I).  A  role  for  protein  kinase  C  in 
neutrophil stimulation has been intimated previously on the 
basis of stimulation of these cells by PMA and/or diacylglyc- 
erol (e.g.,  15,  19,  31).  Diacylglycerol is  thought to be  the 
physiological activator of protein kinase C (26).  Stimulation 
of neutrophils with PMA produces rapid alterations in the 
phosphoproteins of these cells, the identity of which remain 
to be determined (e.g., 2, 40, 47). 
The intracellular vesicles formed upon stimulation of neu- 
trophils with phorbol esters are of interest. These structures 
were  first  reported  in  human  neutrophils  stimulated  with 
PMA (37) and were then shown to occur in neutrophils from 
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guinea pigs  and  mice (5)  and in  munne  macrophages (6). 
Cytoehemical studies on these cells  have shown that these 
vesicles and the plasmalemma stain for hydrogen peroxide (5, 
6). It was speculated that these vesicles were derived, at least 
in part, from the plasmalemma and may be somewhat anal- 
ogous to phagosomes. 
As  noted above, certain phenothiazines (i.e.,  TFP, CPZ) 
and naphthalene sulfonamides (i.e.,  WT) inhibit a variety of 
Ca2÷-binding proteins including protein kinase C (e.g. 21, 32) 
and calmodulin (e.g.,  46).  Calmodulin modulates many of 
the second messenger functions of Ca  2+ by interacting with 
various enzymes and certain elements of the cytoskeleton (for 
reviews, see references 10 and 36). Both protein kinase C and 
calmodulin are present in neutrophils (21, 25). The inhibitory 
effects of phenothiazines and naphthalene sulfonamides de- 
scribed here exhibit properties very similar to those reported 
for purified calmodulin-dependent enzymes. One may point 
in this regard to the order of effectiveness of the phenothia- 
zincs (i.e., TFP>CPZ>PMZ> > >TFP-SO, CPZ-SO) (Table 
II) (34, 46) and naphthalene sulfonamides (W7> >Ws) (Table 
II and Fig. 3) (22), the reversibility of the effects of  these drugs 
(Table II) (46),  and the Hill coefficient for TFP (nil =  3.2, 
Fig. 2 B) (46). Similar data on reversibility and cooperativity 
of  these drugs with purified protein kinase C are not presently 
available.  The concentrations of TFP, CPZ, and W7 required 
for half-maximal inhibition of 02- release (i.e.,  -5,  10, and 
20 uM, respectively) (Figs. 2A and 3) are strikingly similar to those  observed  for calmodulin-dependent  processes  (for re- 
vierS,  see  references  42  and  46)  and  considerably  less  than 
those required to inhibit  protein kinase C  (13,  21,  27).  We 
have  recently  reported  similar  results  with  these  inhibitors 
using human neutrophils stimulated with arachidonate (15). 
However, caution is necessary when comparing kinetic con- 
stants obtained  with purified  proteins  to those obtained  for 
cellular  phenomena  since  parameters  may  be  affected  by 
differences in protein or lipid concentrations (e.g.,  32), assay 
procedures (e.g.,  34), and synergistic effects between the rele- 
vant components (39).  A  previous study on neutrophils ob- 
tained from guinea pig peritonea reported that inhibition of 
02-  release  by  phenothiazines  was  not reversible  (12).  The 
reason for the discrepancy with our results is unknown. 
Addition  of purified  calmodulin  to  membrane  fragments 
from stimulated neutrophils enhanced the activity of the 02-- 
producing  oxidase;  the  ability  of phenothiazines  to  inhibit 
this oxidase in vitro was also reported (25).  White et al.  (47) 
have examined the inhibitory effects of TFP on PMA-induced 
degranulation and protein phosphorylation patterns. Interest- 
ingly, their dose response curve for inhibition ofdegranulation 
and for phosphorylation of a 50,000-mol-wt protein is essen- 
tially identical to that which we present for inhibition of 02- 
release (Fig. 2A). 
Thus, the abilities of several phorbol derivatives in stimu- 
lating neutrophils to release 02- and undergo morphological 
changes has been compared,  and the effectiveness  of several 
phenothiazines  and  naphthalene  sulfonamides  in  blocking 
these processes have been determined.  Additional  work will 
be  required  to  elucidate  the  precise  mechanisms  by which 
these compounds affect neutrophil function. 
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